Targeting the NAD⁺ salvage pathway: roles of NAMPT in the tumor microenvironment
Nicotinamide adenine dinucleotide (NAD⁺) is a central redox cofactor that supports cellular metabolism, redox balance and signal transduction. Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step of NAD⁺ salvage pathway in both malignant and non-malignant cells of the tumor microenvironment (TME). Whilst direct restriction of NAD⁺ metabolism in cancer cells has yielded limited clinical benefit, emerging evidence reveals that NAMPT shapes antitumor immunity by reprogramming immune cell function and the metabolic landscape of the TME. Parallel advances in medicinal chemistry, including bifunctional inhibitors, drug-delivery systems and proteolysis-targeting chimeras (PROTACs) are enabling more selective NAMPT-targeted agents. This review examines the context-dependent roles of NAMPT across immune and stromal compartments of the TME and evaluates emerging therapeutic approaches, highlighting their potential to overcome current limitations and advance NAMPT-targeted immunotherapy.
Authors
- Guiquan Zhu (ORCID: https://orcid.org/0000-0002-8316-5809)
- Shengqi Zhao
- Wanrong Meng (ORCID: https://orcid.org/0009-0008-3210-4126)
- Jinghang Wei
Institutions
- Sichuan University (CN)
- State Key Laboratory of Oral Diseases (CN)
Publication Details
- Journal
- Carcinogenesis
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1093/carcin/bgag083
- Primary Topic
- Sirtuins and Resveratrol in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00